Clinical Trials

90 enrolled

Breast Neoplasms

NCT01036087 2023-03-30

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

47 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00773695 2023-01-09

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

150 enrolled

Breast Neoplasms

NCT01779050 2022-11-01

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells

7 enrolled 8 charts

Breast Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

170 enrolled

Breast Neoplasms

NCT02742051 2021-09-23

A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

40 enrolled

Breast Neoplasms

NCT01593020 2021-09-22

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

54 enrolled 10 charts

Breast Neoplasms

NCT01220128 2021-05-25

INDUCT

66 enrolled 40 charts

Breast Neoplasms

NCT02506777 2019-09-04

MBC1

96 enrolled

Breast Neoplasms

NCT00015886 2018-08-13

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

25 enrolled

Breast Neoplasms

NCT00559845 2018-04-09

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

56 enrolled 10 charts

Breast Neoplasms

NCT02365805 2017-03-13

BERNAQ

30 enrolled

Breast Neoplasms

NCT00499603 2016-11-01

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

62 enrolled 13 charts

Breast Neoplasms

NCT02846428 2016-07-27

To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer

182 enrolled

Breast Neoplasms

NCT00429299 2016-03-22

CHERLOB

121 enrolled 16 charts

Breast Neoplasms

NCT01985841 2015-10-08

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

34 enrolled

Breast Neoplasms

NCT01658033 2015-09-09

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

72 enrolled

Breast Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

15 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00425516 2014-10-01

Breast Cancer Treated by Neoadjuvant Chemotherapy

264 enrolled

Breast Neoplasms

NCT02115152 2014-04-15

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

100 enrolled

Breast Neoplasms

NCT00933517 2014-03-21

TVA

62 enrolled

Breast Neoplasms

NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Breast Neoplasms

NCT00002498 2013-12-18

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

Breast Neoplasms

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

160 enrolled

Breast Neoplasms

NCT00003953 2013-01-28

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

39 enrolled

Breast Neoplasms

NCT01231802 2012-07-17

Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

140 enrolled

Breast Neoplasms

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Breast Neoplasms, Neoplasms, Neutropenia

NCT00003135 2009-04-30

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

34 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Neoplasms

NCT00010075 2008-07-24

Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer

Breast Neoplasms

NCT00001498 2008-03-04

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

55 enrolled